Literature DB >> 18545911

Acute and prophylactic treatments for migraine: present and future.

Alan M Rapoport1.   

Abstract

Herein I will present general principles of acute-care and preventive therapy of migraine, both in the present and the future. Details of currently used migraine acute-care therapies with their contraindications, drug-drug interactions and adverse events will be presented. Details of migraine preventive therapies with their adverse events and drug-drug interactions will be discussed. Some over-the-counter vitamins, minerals and herbs, used as preventive therapy in migraine, will be discussed. Future treatments in the pipeline will be briefly detailed.

Entities:  

Mesh:

Year:  2008        PMID: 18545911     DOI: 10.1007/s10072-008-0901-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  26 in total

1.  Treatment strategies for migraine headache.

Authors:  R K Cady
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

Review 2.  Migraine: preventive treatment.

Authors:  S D Silberstein
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

3.  Lamotrigine versus placebo in the prophylaxis of migraine with and without aura.

Authors:  T J Steiner; L J Findley; A W Yuen
Journal:  Cephalalgia       Date:  1997-04       Impact factor: 6.292

4.  COX-2 inhibitors.

Authors:  C J Hawkey
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

5.  Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Authors:  J Schoenen; J Jacquy; M Lenaerts
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

6.  Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study.

Authors:  G D'Andrea; F Granella; M Cadaldini; G C Manzoni
Journal:  Cephalalgia       Date:  1999-01       Impact factor: 6.292

7.  Fluoxetine and migraine: comparison of double-blind trials.

Authors:  J R Saper; S D Silberstein; A E Lake; M E Winters
Journal:  Headache       Date:  1995-04       Impact factor: 5.887

8.  Efficacy of gabapentin in migraine prophylaxis.

Authors:  N T Mathew; A Rapoport; J Saper; L Magnus; J Klapper; N Ramadan; B Stacey; S Tepper
Journal:  Headache       Date:  2001-02       Impact factor: 5.887

9.  Migraine prophylaxis with divalproex.

Authors:  N T Mathew; J R Saper; S D Silberstein; L Rankin; H G Markley; S Solomon; A M Rapoport; C J Silber; R L Deaton
Journal:  Arch Neurol       Date:  1995-03

10.  Migraine prevalence during menopausal transition.

Authors:  Shuu-Jiun Wang; Jong-Ling Fuh; Shiang-Ru Lu; Kai-Dih Juang; Peng-Hui Wang
Journal:  Headache       Date:  2003-05       Impact factor: 5.887

View more
  7 in total

1.  Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.

Authors:  T Dorosch; C A Ganzer; M Lin; A Seifan
Journal:  Curr Pain Headache Rep       Date:  2019-09-12

2.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128

Review 3.  Role of antiepileptic drugs as preventive agents for migraine.

Authors:  Michail Vikelis; Alan M Rapoport
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

4.  The acute and preventative treatment of episodic migraine.

Authors:  Sarah Miller
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

5.  The efficacy and safety of antiepileptics in the prophylaxis of pediatric migraine: the meta-analysis of randomized controlled trials.

Authors:  Guoyong Jia; Xingbang Wang; Hongbo Lv; Malebo Sarai Cheryl Nonyane; Haiguang Hou; Lin Ma; Peiyan Shan; Xinwei Wu
Journal:  Transl Pediatr       Date:  2021-07

6.  Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine.

Authors:  H-C Diener; D W Dodick; C C Turkel; G Demos; R E Degryse; N L Earl; M F Brin
Journal:  Eur J Neurol       Date:  2014-03-15       Impact factor: 6.089

7.  Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.

Authors:  Licia Grazzi; Cristina Tassorelli; Marina de Tommaso; Giulia Pierangeli; Paolo Martelletti; Innocenzo Rainero; Pierangelo Geppetti; Anna Ambrosini; Paola Sarchielli; Eric Liebler; Piero Barbanti
Journal:  J Headache Pain       Date:  2018-10-19       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.